[法国临床病理学家专注于血液静止的实践概述]
Andréas Perrier-Cornet1, Nicolas Gendron2, Céline Desconclois3
1Laboratoire d'Hématologie, Hôpital Bichat, Assistance Publique Hôpitaux de Paris, 75018 Paris, France.
Annales de biologie clinique
|March 27, 2025
概括
医学生物学家,特别是药剂师,在血液静止的诊断和治疗方面发挥着至关重要的作用. 他们的不断发展的实践需要一个受监管的框架,以确保患者的安全和最佳护理.
科学领域:
- 医学生物学 医学生物学
- 血液静止 血液静止 血液静止
- 临床诊断 临床诊断 临床诊断
背景情况:
- 医学生物学是医学博士 (MD) 和药剂师 (PharmD) 的共同专业.
- 医生对医学生物学的兴趣自2007年以来一直在下降.
- 医学博士和药学博士医学生物学家之间的监管差异在医疗保健中带来了挑战.
研究的目的:
- 调查当前的血液静止咨询和咨询实践.
- 了解医学生物学家在静血中所扮演的角色和所面临的挑战.
- 探索医学生物学家实践范围的发展潜力.
主要方法:
- 在2022年对152名静血专业人员进行了一项调查.
- 受访者包括药剂师-生物学家 (65.1%),医生-生物学家 (27.6%) 和临床医生 (7.2%).
- 该调查评估了诊断建议,治疗建议和血液静止咨询实践.
主要成果:
- 91.9%的受访者提供了诊断建议,75.0%提供了治疗建议.
- 41%的从业者进行了静血咨询,其中24.2%是药剂师.
- 药剂师-生物学家积极参与静血咨询和建议.
结论:
- 医学生物学家,特别是药剂师,在血液静止中发挥着重要但未被认可的作用.
- 需要对他们的实践范围进行受监管和监督的发展.
- 确保安全有效的患者护理需要调整血静专家的实践.
更多相关视频
05:49Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
Published on: November 29, 2024
459
10:25Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro
Published on: March 19, 2016
9.3K
相关概念视频
Disorders of Hemostasis
676
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
676
Extrinsic and Intrinsic Pathways of Hemostasis
4.6K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
4.6K
Introduction to Hemostasis
4.8K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
4.8K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
588
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
588
